Author: Business Wire

Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD)

PHILADELPHIA–(BUSINESS WIRE)– #biotechnology–Exegenesis Bio, a rapidly growing global gene therapy company is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for EXG102-…

Bausch + Lomb Acquires AcuFocus, Inc.

VAUGHAN, Ontario & IRVINE, Calif.–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately he…

Worldwide Ophthalmic Lasers Industry to 2029 – Rise in Eye-related Conditions Such as Refractive Errors, Cataracts and Glaucoma Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers Market Analysis, By Application, By Type, By End User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic lasers market size is estimated t…